Kay, J., Fleischmann, R., Keystone, E., Hsia, E. C., Hsu, B., Mack, M., . . . Kavanaugh, A. (2015). Golimumab 3-year safety update: An analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Ann Rheum Dis.
Dyfyniad Arddull ChicagoKay, Jonathan, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Michael Mack, Neil Goldstein, Jürgen Braun, and Arthur Kavanaugh. "Golimumab 3-year Safety Update: An Analysis of Pooled Data From the Long-term Extensions of Randomised, Double-blind, Placebo-controlled Trials Conducted in Patients With Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis." Ann Rheum Dis 2015.
Dyfyniad MLAKay, Jonathan, et al. "Golimumab 3-year Safety Update: An Analysis of Pooled Data From the Long-term Extensions of Randomised, Double-blind, Placebo-controlled Trials Conducted in Patients With Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis." Ann Rheum Dis 2015.